Literature DB >> 25920740

Erectile dysfunction: a window to the heart.

Vitaliy Androshchuk1, Neil Pugh1, Andrew Wood1, Nick Ossei-Gerning1.   

Abstract

Erectile dysfunction (ED) is an early marker of coronary artery disease (CAD) and often manifests before the development of symptomatic CAD. In this case report, we present a 60-year-old man with ED, who demonstrated limited response to the standard management strategies and was subsequently treated with percutaneous pelvic intervention (PPI) of the internal pudendal artery. While on the table for PPI, the patient described a classical history of angina, on which basis he underwent coronary angiography and was found to have narrow proximal left anterior descending stenosis. Coronary artery stent placement was then performed using standard techniques. PPI of pudendal artery stenoses with stents is feasible and can improve cavernosal blood flow and venous leakage as well as erectile function. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25920740      PMCID: PMC4422912          DOI: 10.1136/bcr-2015-210124

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences.

Authors:  I A Ayta; J B McKinlay; R J Krane
Journal:  BJU Int       Date:  1999-07       Impact factor: 5.588

2.  Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study.

Authors:  Charalambos Vlachopoulos; Konstantinos Rokkas; Nikolaos Ioakeimidis; Constadina Aggeli; Andreas Michaelides; Georgios Roussakis; Charalambos Fassoulakis; Athanasios Askitis; Christodoulos Stefanadis
Journal:  Eur Urol       Date:  2005-08-24       Impact factor: 20.096

3.  Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.

Authors:  Konstantinos Hatzimouratidis; Edouard Amar; Ian Eardley; Francois Giuliano; Dimitrios Hatzichristou; Francesco Montorsi; Yoram Vardi; Eric Wespes
Journal:  Eur Urol       Date:  2010-02-20       Impact factor: 20.096

4.  Erectile dysfunction and coronary artery disease prediction: evidence-based guidance and consensus.

Authors:  G Jackson; N Boon; I Eardley; M Kirby; J Dean; G Hackett; P Montorsi; F Montorsi; C Vlachopoulos; R Kloner; I Sharlip; M Miner
Journal:  Int J Clin Pract       Date:  2010-06       Impact factor: 2.503

Review 5.  Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient.

Authors:  Piero Montorsi; Paolo M Ravagnani; Stefano Galli; Andrea Salonia; Alberto Briganti; José P Werba; Francesco Montorsi
Journal:  Eur Urol       Date:  2006-07-28       Impact factor: 20.096

Review 6.  Erectile dysfunction in the cardiovascular patient.

Authors:  Charalambos Vlachopoulos; Graham Jackson; Christodoulos Stefanadis; Piero Montorsi
Journal:  Eur Heart J       Date:  2013-04-24       Impact factor: 29.983

7.  Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors.

Authors:  Jason H Rogers; Irwin Goldstein; David E Kandzari; Tobias S Köhler; Curtiss T Stinis; Paula J Wagner; Jeffrey J Popma; Michael R Jaff; Krishna J Rocha-Singh
Journal:  J Am Coll Cardiol       Date:  2012-11-21       Impact factor: 24.094

8.  Cavernous artery intima-media thickness: a new parameter in the diagnosis of vascular erectile dysfunction.

Authors:  Nicola Caretta; Pierfrancesco Palego; Mirko Schipilliti; Alberto Ferlin; Antonella Di Mambro; Carlo Foresta
Journal:  J Sex Med       Date:  2008-12-05       Impact factor: 3.802

Review 9.  Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies.

Authors:  Charalambos V Vlachopoulos; Dimitrios G Terentes-Printzios; Nikolaos K Ioakeimidis; Konstantinos A Aznaouridis; Christodoulos I Stefanadis
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-01-08

10.  Treatment Strategy for Non-Responders to PDE5 Inhibitors.

Authors:  Nam Cheol Park; Tae Nam Kim; Hyun Jun Park
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

View more
  2 in total

Review 1.  Relationship between hyperuricemia with deposition and sexual dysfunction in males and females.

Authors:  A Sansone; Y Reisman; E A Jannini
Journal:  J Endocrinol Invest       Date:  2022-01-08       Impact factor: 5.467

2.  ST-elevation Myocardial Infarction and Complete Heart Block in a Nitrate-free Patient using a New Emerging Substance called Rhino.

Authors:  Smit Deliwala; Tarek Haykal; Harsukh Dhillon; Saadia Shafi; Ghassan Bachuwa
Journal:  Cureus       Date:  2020-04-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.